imatinib mesylate has been researched along with Priapism in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bohra, GK; Kumar, D; Pandey, H; Purohit, AHL; Saha, S; Sarangi, S | 1 |
| Clark, AJ; Darves-Bornoz, A; Hsu, P; Katzenstein, HM; Mason, EF; Tanaka, ST | 1 |
| AbdelRahman, IF; El-Haddad, MS; Selim, OM; Shaeer, KZ; Shaeer, OK | 1 |
1 review(s) available for imatinib mesylate and Priapism
| Article | Year |
|---|---|
Priapism as a result of chronic myeloid leukemia: case report, pathology, and review of the literature.
Topics: Antineoplastic Agents; Benzamides; Cryopreservation; Endothelium, Vascular; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Penile Prosthesis; Piperazines; Priapism; Pyrimidines; Semen Preservation; Treatment Outcome; Young Adult | 2015 |
2 other study(ies) available for imatinib mesylate and Priapism
| Article | Year |
|---|---|
Is Priapism a Common Presentation of Chronic Myeloid Leukemia in an Adolescent Patient?
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Priapism | 2021 |
Case 3: Priapism in a 13-year-old Boy.
Topics: Adolescent; Antineoplastic Agents; Blood Cell Count; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukostasis; Male; Priapism | 2018 |